Suppr超能文献

放射性导向手术联合镓 68 喷曲肽用于神经内分泌肿瘤患者。

Radioguided Surgery With Gallium 68 Dotatate for Patients With Neuroendocrine Tumors.

机构信息

Endocrine Oncology Branch, National Cancer Institute, Bethesda, Maryland.

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

JAMA Surg. 2019 Jan 1;154(1):40-45. doi: 10.1001/jamasurg.2018.3475.

Abstract

IMPORTANCE

Neuroendocrine tumors (NETs) express somatostatin receptors, which can be targeted with radiolabeled peptides. In a variety of solid tumors, radioguided surgery (RGS) has been used to guide surgical resection. Gallium 68 (68Ga) dota peptides have been shown to be more accurate than other radioisotopes for detecting NETs. A pilot study previously demonstrated the feasibility and safety of 68Ga-dotatate RGS for patients with NETs.

OBJECTIVE

To evaluate what intraoperative techniques and thresholds define positive lesions that warrant resection during 68Ga-dotatate RGS.

DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study, conducted between October 23, 2013, and February 14, 2018, included 44 patients with NETs who underwent 68Ga-dotatate RGS.

INTERVENTION

Gallium 68-dotatate RGS.

MAIN OUTCOMES AND MEASURES

The in vivo and ex vivo tumor to background ratio (TBR) was assessed for resected lesions and correlated with the histopathologic findings.

RESULTS

Forty-four patients (22 women and 22 men; mean [SD] age, 51.0 [13.7] years) had 133 lesions detected on preoperative imaging scans, with a diagnosis of a pancreatic NET (19 of 44 [43%]), gastrointestinal NET (22 of 44 [50%]), and pheochromocytoma or paraganglioma (3 of 44 [7%]). The TBR was obtained by normalizing to the omentum (106 of 133 [79.7%]) or other solid organs (27 of 133 [20.3%]). The omentum had a significantly lower mean (SD) count than other solid organs for background count activity 3 hours after injection (22.1 [17.0] vs 34.5 [39.0]; P < .001). The lesions containing NETs had a higher TBR than those that did not contain NETs (18.9 vs 4.4; P < .001). On a receiver operating characteristic curve analysis, a TBR of 2.5 had a sensitivity of 90% and a specificity of 25%, and a TBR of 16 had a sensitivity of 54% and a specificity of 81%.

CONCLUSIONS AND RELEVANCE

A TBR of 2.5 or greater is a highly sensitive threshold for indicating a lesion to be consistent with a NET on histologic findings and thus warranting surgical resection. The omentum should be used as the background count activity for 68Ga-dotatate RGS for patients with abdominal NETs.

摘要

重要性

神经内分泌肿瘤 (NET) 表达生长抑素受体,可用放射性标记肽靶向。在各种实体肿瘤中,放射性导向手术 (RGS) 已用于指导手术切除。镓 68(68Ga)dota 肽已被证明比其他放射性同位素更能准确地检测 NET。一项初步研究先前证明了 68Ga-dotatate RGS 用于 NET 患者的可行性和安全性。

目的

评估 68Ga-dotatate RGS 中定义需要切除的阳性病变的术中技术和阈值。

设计、地点和参与者:这项前瞻性队列研究于 2013 年 10 月 23 日至 2018 年 2 月 14 日进行,包括 44 名接受 68Ga-dotatate RGS 的 NET 患者。

干预措施

镓 68-dotatate RGS。

主要结果和措施

对切除的病变进行体内和体外肿瘤与背景比(TBR)评估,并与组织病理学发现相关联。

结果

44 名患者(22 名女性和 22 名男性;平均[标准差]年龄 51.0[13.7]岁)在术前影像学扫描中发现 133 个病变,诊断为胰腺 NET(19/44 [43%])、胃肠道 NET(22/44 [50%])和嗜铬细胞瘤或副神经节瘤(3/44 [7%])。通过将腹膜(133 个中的 106 个[79.7%])或其他实体器官(133 个中的 27 个[20.3%])标准化来获得 TBR。与其他实体器官相比,注射后 3 小时腹膜的背景计数活性具有明显更低的平均值(标准差)计数(22.1[17.0]与 34.5[39.0];P < .001)。包含 NET 的病变的 TBR 高于不包含 NET 的病变(18.9 与 4.4;P < .001)。在受试者工作特征曲线分析中,TBR 为 2.5 时的灵敏度为 90%,特异性为 25%,TBR 为 16 时的灵敏度为 54%,特异性为 81%。

结论和相关性

TBR 为 2.5 或更高是指示病变与组织学发现一致的 NET 的高度敏感阈值,因此需要手术切除。对于腹部 NET 患者,应使用腹膜作为 68Ga-dotatate RGS 的背景计数活性。

相似文献

1
Radioguided Surgery With Gallium 68 Dotatate for Patients With Neuroendocrine Tumors.
JAMA Surg. 2019 Jan 1;154(1):40-45. doi: 10.1001/jamasurg.2018.3475.
2
Feasibility of Radio-Guided Surgery with ⁶⁸Gallium-DOTATATE in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors.
Ann Surg Oncol. 2015 Dec;22 Suppl 3(Suppl 3):S676-82. doi: 10.1245/s10434-015-4857-9. Epub 2015 Sep 8.
4
Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
J Nucl Med. 2013 Mar;54(3):364-72. doi: 10.2967/jnumed.112.111724. Epub 2013 Jan 7.
5
Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis.
Acta Radiol. 2014 May;55(4):389-98. doi: 10.1177/0284185113496679. Epub 2013 Aug 8.
7
Prognostic Utility of Total Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine Tumors.
Gastroenterology. 2018 Mar;154(4):998-1008.e1. doi: 10.1053/j.gastro.2017.11.008. Epub 2017 Nov 16.
9
Radioguided surgery with radiolabeled somatostatin analogs: not only in GEP-NETs.
Nucl Med Rev Cent East Eur. 2017;20(1):49-56. doi: 10.5603/NMR.2017.0003.
10
Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.
Recent Results Cancer Res. 2013;194:353-71. doi: 10.1007/978-3-642-27994-2_18.

引用本文的文献

2
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours.
Curr Oncol Rep. 2025 Feb;27(2):157-167. doi: 10.1007/s11912-024-01632-4. Epub 2025 Jan 25.
3
Detection properties of indium-111 and IRDye800CW for intraoperative molecular imaging use across tissue phantom models.
J Biomed Opt. 2025 Jan;30(Suppl 1):S13705. doi: 10.1117/1.JBO.30.S1.S13705. Epub 2024 Sep 20.
4
Beta Probe for Radioguided Surgery in Gastrointestinal Neuroendocrine Tumors: A Move in the Right Direction.
Ann Surg Oncol. 2024 Jul;31(7):4159-4160. doi: 10.1245/s10434-024-15439-x. Epub 2024 May 14.
5
ASO Author Reflections: Radio-Guided Surgery in Small Intestine Neuroendocrine Tumors: New Probe, New Perspectives?
Ann Surg Oncol. 2024 Jul;31(7):4199-4200. doi: 10.1245/s10434-024-15390-x. Epub 2024 May 9.
10
Radioguided Surgery for Gastroenteropancreatic Neuroendocrine Tumours: a Systematic Literature Review.
J Gastrointest Surg. 2021 Dec;25(12):3244-3257. doi: 10.1007/s11605-021-05115-w. Epub 2021 Sep 10.

本文引用的文献

1
Advances in radioguided surgery in oncology.
Q J Nucl Med Mol Imaging. 2017 Sep;61(3):247-270. doi: 10.23736/S1824-4785.17.02995-8. Epub 2017 Jun 1.
2
Radioguided surgery with radiolabeled somatostatin analogs: not only in GEP-NETs.
Nucl Med Rev Cent East Eur. 2017;20(1):49-56. doi: 10.5603/NMR.2017.0003.
3
Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions.
J Nucl Med. 2016 Dec;57(12):1949-1956. doi: 10.2967/jnumed.116.179234. Epub 2016 Nov 3.
4
Minimally invasive radioguided parathyroid surgery: A literature review.
Int J Surg. 2016 Apr;28 Suppl 1:S84-93. doi: 10.1016/j.ijsu.2015.12.037. Epub 2015 Dec 23.
6
Feasibility of Radio-Guided Surgery with ⁶⁸Gallium-DOTATATE in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors.
Ann Surg Oncol. 2015 Dec;22 Suppl 3(Suppl 3):S676-82. doi: 10.1245/s10434-015-4857-9. Epub 2015 Sep 8.
7
Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis.
Acta Radiol. 2014 May;55(4):389-98. doi: 10.1177/0284185113496679. Epub 2013 Aug 8.
8
Response after surgical resection of metastatic pheochromocytoma and paraganglioma: can postoperative biochemical remission be predicted?
J Am Coll Surg. 2013 Sep;217(3):489-96. doi: 10.1016/j.jamcollsurg.2013.04.027. Epub 2013 Jul 25.
9
High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours.
J Med Imaging Radiat Oncol. 2012 Feb;56(1):40-7. doi: 10.1111/j.1754-9485.2011.02327.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验